Skip to main content
OpenTrials

Clinical trial condition

Mycosis Fungoides

Explore clinical trials studying Mycosis Fungoides. Study availability and eligibility vary by location and protocol.

307 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Mycosis Fungoides trial results

Completed

Photopheresis as an Interventional Therapy for the Treatment of CTCL (Cutaneous T-Cell Lymphoma, Mycosis Fungoides) Stage 1A, 1B, 2A

NCT00221039

Conditions
Cutaneous T Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Rush-Presbyterian Hospital Chicago, Illinois, United States
  • Boston Medical Center Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • University Hospital of Cleveland/Case Western Reserve University Cleveland, Ohio, United States
View Trial Details
Completed

Liposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell Lymphoma

NCT00255801

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Hackensack University Medical Center Cancer Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • NYU Cancer Institute at New York University Medical Center New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View Trial Details
Completed

Liposomal Doxorubicin in Treating Patients With Stage IIB, Stage IVA, or Stage IVB Recurrent or Refractory Mycosis Fungoides

NCT00074087

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Karl-Franzens-University Graz Graz, Austria
  • Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria
  • Universitaetsklinikum Essen Essen, Germany
  • Klinikum der Friedrich-Schiller Universitaet Jena Jena, Germany
View Trial Details
Completed

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

NCT00961220

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +13 more
Locations
  • Henry Ford Hospital Detroit, Michigan, United States
  • Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Case Western Reserve University Cleveland, Ohio, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Completed

Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma

NCT01567709

Conditions
Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Anaplastic Large Cell Lymphoma, +84 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Penn State Milton S Hershey Medical Center Hershey, Pennsylvania, United States
View Trial Details
Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
View Trial Details

Related conditions